Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy IMV (IMV) stocks in Canada

Learn how to easily invest in IMV stocks.

IMV Inc
NASDAQ: IMV - USD
$1.16
- $0.01 ( - 0.85%)
BIOTECHNOLOGY

IMV (IMV) is a leading biotechnology business based in the US. It opened the day at $2.32 after a previous close of $2.34. During the day the price has varied from a low of $2.32 to a high of $2.38. The latest price was $2.339 (25 minute delay). IMV is listed on the NASDAQ and employs 77 staff. All prices are listed in US Dollars.

How to buy shares in IMV

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IMV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

IMV stock price (NASDAQ:IMV)

Use our graph to track the performance of IMV stocks over time.

IMV shares at a glance

Information last updated 2021-06-16.
Open$2.32
High$2.38
Low$2.32
Close$2.34
Previous close$2.34
Change $0.00
Change % -0.0427%
Volume 26,280
Information last updated 2022-01-24.
52-week range$1.09 - $4.60
50-day moving average $1.40
200-day moving average $1.85
Wall St. target price$7.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.48

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy IMV stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

IMV price performance over time

Historical closes compared with the close of $2.339 from 2022-01-25

1 week (2022-01-15) N/A
1 month (2021-12-23) 79.92%
3 months (2021-10-26) 48.98%
6 months (2021-07-26) 14.10%
1 year (2021-01-26) -33.93%
2 years (2020-01-24) -44.18%
3 years (2019-01-25) 5.67
5 years (2017-01-26) 334.76%

IMV financials

Revenue TTM $2,373
Gross profit TTM $-26,602,000
Return on assets TTM -47.23%
Return on equity TTM -97.27%
Profit margin 0%
Book value $0.40
Market capitalisation $95.3 million

TTM: trailing 12 months

IMV share dividends

We're not expecting IMV to pay a dividend over the next 12 months.

Have IMV's shares ever split?

IMV's shares were split on a 312:1000 basis on 10 May 2018. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 312 shares. This wouldn't directly have changed the overall worth of your IMV shares – just the quantity. However, indirectly, the new 220.5% higher share price could have impacted the market appetite for IMV shares which in turn could have impacted IMV's share price.

IMV share price volatility

Over the last 12 months, IMV's shares have ranged in value from as little as $1.09 up to $4.6. A popular way to gauge a stock's volatility is its "beta".

IMV.US volatility(beta: 1.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IMV's is 1.8069. This would suggest that IMV's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

IMV overview

IMV Inc. , a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company's lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck's Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site